A customer, partner or auditor has asked you for a batch release certificate, or one has arrived with your paperwork, and you want to know what it is. If you were asked for a “QP release certificate” or a “QP certificate”, the same documents apply. In the EU, a qualified person (QP) certifies each batch before it is released, and EU law and Annex 16 describe four records around that certification: a register entry, a batch certificate, a confirmation from a partial-manufacturing site and a control report.
Key Takeaways
- The QP certifies each production batch in a register or equivalent document, kept up to date and available to the competent authority for at least five years (Article 51(3) of Directive 2001/83/EC).
- Annex 16 Appendix II sets out the contents of a batch certificate: seven items on the certifying manufacturer’s letterhead, including a signed certification statement.
- Annex 16 Appendix I sets out a confirmation used where QP responsibilities for a batch pass between sites.
- Batches controlled in one Member State are exempt from the controls when marketed in another, if accompanied by the control reports signed by the QP (Article 51(1)).
What is a batch release certificate?
Annex 16 of the EU GMP guide, the guidance on QP certification and batch release, opens its main rule in section 1.1: “Each batch of finished product must be certified by a QP within the EU before being released for sale or supply in the EU or for export.” A footnote to the word “certified” names a document: “The contents of a batch certificate for medicinal products are presented in Appendix II to this Annex.” When someone asks for a batch release certificate, this batch certificate is the closest document in Annex 16.
The certification itself is recorded elsewhere. The Annex 16 glossary defines certification of the finished product batch as “The certification in a register or equivalent document by a QP … and represents the quality release of the batch before the batch is released for sale or distribution.” The certification sits in the QP’s register. The batch certificate is a separate document. Appendix II sets out its contents, including a certification statement signed by the QP.
Certification comes first: the QP’s register entry
Article 51(3) of Directive 2001/83/EC says “the qualified person must certify in a register or equivalent document provided for that purpose, that each production batch satisfies the provisions of this Article”. The register “must be kept up to date as operations are carried out and must remain at the disposal of the agents of the competent authority for the period specified in the provisions of the Member State concerned and in any event for at least five years.”
Annex 16 section 1.10.1 repeats this. The register entry is the record EU law requires for each production batch.
Until the QP certifies, the batch waits. Under Annex 16 section 4.1, a batch “should remain at the site of manufacture or be shipped under quarantine to another site which has been approved for that purpose by the relevant Competent Authority.” Our post on what happens before QP certification covers that quarantine stage, and our guide to what the QP checks before certification covers the review behind the register entry.
What a batch release certificate contains (Annex 16 Appendix II)
Appendix II of Annex 16 sets out the contents of a batch certificate, the Annex 16 document closest to a “batch release certificate”. It is headed with the letterhead of the batch certifying and releasing manufacturer, and it contains seven items:
- The name, strength or potency, dosage form and package size, identical to the text on the finished product package.
- The batch number of the finished product.
- The destination country or countries of the batch, at least when within the EU.
- The certification statement.
- The name of the QP.
- The QP’s signature.
- The date of signature.
The certification statement reads: “I hereby certify that all the manufacturing stages of this batch of finished product have been carried out in full compliance with the GMP requirements of the EU and [when within the EU] with the requirements of the Marketing Authorisation(s) of the destination country/countries.”
The confirmation of partial manufacturing (Appendix I)
Annex 16 section 1.3 notes that “There may be several sites involved in the various stages of manufacture, importation, testing and storage of a batch before it undergoes certification.” Section 1.4.1 says that where a site in the EU carries out only part of the manufacture of a batch, a QP at that site must “at least confirm that the operations undertaken by the site have been performed in accordance with GMP and the terms of the written agreement”. A footnote points to Appendix I for the information required “where QP responsibilities for the batch are being transferred between sites”.
The glossary defines a confirmation as “A signed statement by a QP that a process or test has been conducted in accordance with GMP and the relevant marketing authorisation or clinical trial authorisation, product specification file and/or technical agreement, as applicable, as agreed in writing with the QP responsible for certifying the finished product batch before release.”
Appendix I lists its contents, on the letterhead of the manufacturer that carried out the activity:
- The name of the product and the stage of manufacture, for example “paracetamol 500 mg tablets, primary packaging into blister packs”.
- The batch number.
- The name and address of the site.
- A reference to the Technical Quality Agreement (Chapter 7 of the EU GMP guide).
- The confirmation statement.
- The name of the QP.
- The QP’s signature.
- The date of signature.
The statement reads: “I hereby confirm that the manufacturing stages referred to in the Technical Quality Agreement have been carried out in full compliance with the GMP requirements of the EU and the terms described in the Agreement for ensuring compliance with the requirements of the Marketing Authorisation(s) as provided by [Contract Giver/manufacturer certifying and releasing the batch].”
A confirmation covers only the stages one site carried out. The QP responsible for the finished batch still certifies it under section 1.1.
Moving a batch to another Member State: the control report
Article 51(1) of the Directive ends with this rule: “The batches of medicinal products which have undergone such controls in a Member State shall be exempt from the controls if they are marketed in another Member State, accompanied by the control reports signed by the qualified person.”
Annex 16 section 1.10.2 applies it: “The control report referred to in Article 51 … or another proof for release to the market in question, based on an equivalent system, should be made available for the batch in order to be exempted from further controls when entering another Member State.” In other words, instead of the control report, Annex 16 accepts another proof for release to the market in question, based on an equivalent system.
What a batch release certificate is not: CoA, GMP certificate and MIA
None of these three documents certifies a batch.
Certificate of analysis
A certificate of analysis (CoA) is a report of test results. EMA’s GMP/GDP questions and answers use it in that sense: data from outsourced activities “are routinely provided as summary data in a report format (e.g. CoA)” (data integrity, question 20). A CoA reports a laboratory’s results. It is not the QP’s certification.
GMP certificate
Under Article 111(5) of the Directive, a GMP certificate “shall, when applicable, be issued to the inspected entity if the outcome of the inspection shows that it complies” with GMP. EMA’s good manufacturing practice page says: “After inspecting a manufacturing site, EU competent authorities issue a GMP certificate or a non-compliance statement, which is entered in the EudraGMDP database.” The EMA questions and answers add that “GMP certificates are site-specific” and that “the competent authority responsible for carrying out the inspection issues the GMP certificate”. A GMP certificate covers a site, not a batch.
MIA
An “MIA certificate” refers to the MIA, the manufacturing or import authorisation. Under Article 40(1) of the Directive, manufacture “is subject to the holding of an authorization”, and under Article 40(3) that authorisation “shall also be required for imports coming from third countries into a Member State”. An MIA authorises a holder to manufacture or import. It is not a batch document.
How Inglasia can help
Inglasia’s QPs review manufacturing records, technical documentation and test results, and certify batches under Annex 16. Our QP batch release services page describes the service, and our Annex 16 certification page covers batch certification under Annex 16. For the factors that affect timing, see our post on how long batch release takes. To discuss your batches, contact us.





